Over-the-counter cough medicines: New approaches

Morice, Alyn H.

Abstract

© 2015 Elsevier Ltd. The global market for over-the-counter (OTC) medicines in the category cough/cold is enormous amounting to 5.77 billion euro in 2014 (source IMS). Despite this enormous healthcare investment, mainly by direct consumer purchase, evidence for efficacy is poor by modern standards. Because of a lack of new drug development existing OTC medicines are supported by trials of inadequate design. This has led to the claim that cough medicines are inefficacious. Recent developments in measuring cough support some existing agents but investment in modern studies to provide comprehensive proof of efficacy has not happened. The switch from prescription medicine to OTC which has occurred in other markets will not occur in antitussives since novel therapies have yet to be developed. One area, that of herbal derived medicines, has seen innovation because it is less hampered by regulatory constraints.

Citation

Morice, A. H. (2015). Over-the-counter cough medicines: New approaches. Pulmonary Pharmacology and Therapeutics, 35, 149-151. https://doi.org/10.1016/j.pupt.2015.07.006

• Journal Article Type: Review
• Acceptance Date: Jul 25, 2015
• Online Publication Date: Jul 30, 2015
• Publication Date: 2015-12
• Deposit Date: May 16, 2022
• Journal: Pulmonary Pharmacology and Therapeutics
• Print ISSN: 1094-5539
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 35
• Pages: 149-151
• DOI: https://doi.org/10.1016/j.pupt.2015.07.006
• Public URL: https://hull-repository.worktribe.com/output/3610020